From: DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Clinicopatholog-ical variables | DLC1 expression | RhoA expression | Rock2 expression | moesin expression | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
H | L | p | H | L | p | H | L | p | H | L | p | |
Gender | ||||||||||||
Male | 23 | 38 | 0.731 | 48 | 13 | 0.98 | 46 | 15 | 0.879 | 55 | 8 | 0.29 |
Female | 8 | 11 | 15 | 4 | 14 | 5 | 15 | 4 | ||||
Age (years) | ||||||||||||
< 45 | 9 | 14 | 0.958 | 17 | 6 | 0.502 | 17 | 6 | 0.887 | 19 | 4 | 0.548 |
≥ 45 | 22 | 35 | 46 | 11 | 43 | 14 | 50 | 7 | ||||
Tumor number | ||||||||||||
Singel | 20 | 30 | 0.767 | 40 | 10 | 0.724 | 39 | 11 | 0.424 | 43 | 7 | 0.933 |
Multiple | 11 | 19 | 23 | 7 | 21 | 9 | 26 | 4 | ||||
Maximal tumor size (cm) | ||||||||||||
< 5 | 19 | 30 | 0.995 | 38 | 11 | 0.742 | 37 | 13 | 0.789 | 43 | 6 | 0.623 |
≥ 5 | 12 | 19 | 25 | 6 | 23 | 7 | 26 | 5 | ||||
Tumor differentiation | ||||||||||||
I-II | 12 | 49 | <0.001 | 36 | 15 | 0.018 | 33 | 18 | <0.001 | 41 | 10 | 0.043 |
III-IV | 19 | 10 | 27 | 2 | 27 | 2 | 28 | 1 | ||||
HBV infection | ||||||||||||
No | 7 | 11 | 0.989 | 14 | 4 | 0.909 | 13 | 5 | <0.001 | 15 | 3 | 0.683 |
Yes | 24 | 38 | 49 | 13 | 47 | 15 | 54 | 8 | ||||
TNM stage | ||||||||||||
I-II | 11 | 43 | <0.001 | 39 | 15 | 0.034 | 37 | 17 | 0.002 | 44 | 10 | 0.074 |
III | 20 | 6 | 24 | 2 | 23 | 3 | 25 | 1 | ||||
Portal vein invasion and dissemination | ||||||||||||
Yes | 8 | 38 | <0.001 | 39 | 7 | <0.001 | 40 | 6 | 0.004 | 43 | 3 | 0.029 |
No | 23 | 11 | 14 | 20 | 20 | 14 |